BIO issued statement regarding U.S. Patent and Trademark Office’s proposed changes to rules governing Patent Trial and Appeal Board inter partes review proceedings. BIO appreciates PTO’s efforts to improve IPR proceedings, but it is clear that these moderate improvements do not adequately address fundamental problems with IPR system. Proposed changes would do little to prevent continuing and growing abuse of IPR proceedings, and only reinforce need for Congressional action to fix this system.